Pharmaceutical Dissolution Testing Services Market Worth $1.2 Billion By 2030

Pharmaceutical Dissolution Testing Services Market Growth & Trends

The global pharmaceutical dissolution testing services market size is expected to reach USD 1.2 billion by 2030, registering a CAGR of 8.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to increase primarily as a result of the rising drug development process, increasing technological advancements, rising awareness about the need for high-quality products, and the production of numerous medications for various chronic diseases that require dissolution testing. The COVID-19 pandemic has significantly impacted the global industry. Pharmaceutical firms, biotech firms, and other end-user demands were primarily served during the crisis by developing coronavirus prevention drugs.

Since the end of 2019, these organizations have been actively working toward the development of medications that can be used as a treatment for COVID-19 patients who have only minor symptoms. And these drug developments require dissolution testing at each stage to access safety, stability, and efficacy, thus contributing to industry growth. For the physical assessment of solid dosage forms, such as tablets, capsules, ointments, and creams, dissolution testing is required. The simplest type of testing measures the solubility or rate of dissolving a medication tablet. Dissolution testing can be performed to assess the release rates of a drug material under various situations and to provide details regarding the effectiveness of in vivo performance in Absorption, Distribution, Metabolism, And Excretion (ADME) and bioavailability studies.

Dissolution testing provides information on how quickly or slowly certain drugs are absorbed into various body parts and, subsequently, how much they dissolve after administration. This enables businesses to assess whether a drug will function effectively after it enters a patient's system and whether any negative effects brought on by slower absorption rates would occur. Pharmaceutical dissolution testing requires specialized staff to run the assays and prepare regulatory filings. This factor has greatly increased the demand for professional teams to handle pharmaceutical dissolution testing, which is predicted to have a favorable effect on the industry.

 Request a free sample copy or view the report summary: Pharmaceutical Dissolution Testing Services Market Report

Pharmaceutical Dissolution Testing Services Market Report Highlights

• The in vitro method segment accounted for the largest revenue share in 2022

• The tablets dosage form segment accounted for the largest share and is anticipated to grow at the fastest CAGR during the forecast period

• Tablets have high physical and chemical stability and the amount of drug delivered to the body can be controlled

• Based on dissolution apparatus, the paddle segment dominated the industry in 2022 as it can cover a range of oral dosage forms

• North America dominated the industry in 2022owing to rising investments by public firms in research and their state-of-the-art research infrastructure

Pharmaceutical Dissolution Testing Services Market Segmentation

Grand View Research has segmented the global pharmaceutical dissolution testing services market based on method, dosage form, dissolution apparatus, and region:

Pharmaceutical Dissolution Testing Services Method Outlook (Revenue, USD Million, 2018 - 2030)

• In vitro

• In vivo

Pharmaceutical Dissolution Testing Services Dosage Form Outlook (Revenue, USD Million, 2018 - 2030)

• Capsules

• Tablets

• Others

Pharmaceutical Dissolution Testing Services Dissolution Apparatus Outlook (Revenue, USD Million, 2018 - 2030)

• Basket

• Paddle

• Others

Pharmaceutical Dissolution Testing Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Europe

• U.K.

• Germany

• France

• Italy

• Spain

• Asia Pacific

• China

• India

• Japan

• South Korea

• Australia

• Latin America

• Brazil

• Mexico

• Argentina

• Middle East & Africa

• South Africa

• Saudi Arabia

• UAE

List of Key Players in Pharmaceutical Dissolution Testing Services Market

• Intertek Group Plc.

• Avivia BV

• Almac Group

• Agilent Technologies, Inc.

• Catalent, Inc.

• Thermofisher Scientific Inc.

• Cambrex Corp.

• Charles River Laboratories

• Boston Analytical

• Pace Analytical Life Sciences

• SOTAX

• AMRI

• SGS SA